Prof Thomas Helleday presents MTHFD2 and other emerging targets such as PKMYT1, MTH1 and Pol Theta at the AACR21 virtual meeting.
Dr Eva Ehrnrooth, MD PhD to join One-carbon Therapeutics AB management team as interim CMO
Dr Eva Ehrnrooth (MD PhD) brings + 20 years of
